Cancel
Known information
- Has more than 29 years of finance and accounting experience.
- Has spent the last twenty-two years servicing biotechnology, pharmaceutical, medical device, and clinical research companies.
- Previously served as CFO at Lipocine Inc., Innovus Pharmaceuticals, World Heart Corporation, Lifetree Clinical Research, and NPS Pharmaceuticals.
- Worked for KPMG LLP as a Senior Audit Manager in Salt Lake City.
- Participated in and led efforts to successfully evaluate, negotiate, and close transactions including equity and debt financings totaling over $1 billion.
- Led out-licensing of commercial stage asset transactions totaling $220 million.
- Has experience in sale-leaseback arrangements, facilities construction, and M&A activities.
- Is a licensed certified public accountant in the state of Utah.
- Earned a Master of Science degree in Business Administration from the University of Utah.
- Holds a Bachelor of Science degree in Accounting from Utah State University.
About Clene Nanomedicine
Clene Nanomedicine is a biopharmaceutical company focused on developing nanotherapeutics for neurodegenerative diseases, with its lead candidate, CNM-Au8, targeting ALS, MS, and Parkinson's Disease.
Report inaccurate information
